KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) EPS (Weighted Average and Diluted) (2021 - 2025)

ClearPoint Neuro's EPS (Weighted Average and Diluted) history spans 8 years, with the latest figure at -$0.21 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) fell 16.67% year-over-year to -$0.21; the TTM value through Sep 2025 reached -$0.83, down 20.29%, while the annual FY2024 figure was -$0.7, 22.22% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.21 at ClearPoint Neuro, down from -$0.2 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.13 in Q1 2021 and bottomed at -$0.29 in Q2 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.18 (2022), against an average of -$0.19.
  • The largest annual shift saw EPS (Weighted Average and Diluted) tumbled 61.11% in 2023 before it skyrocketed 44.83% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.21 in 2021, then increased by 14.29% to -$0.18 in 2022, then dropped by 5.56% to -$0.19 in 2023, then decreased by 5.26% to -$0.2 in 2024, then decreased by 5.0% to -$0.21 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's EPS (Weighted Average and Diluted) are -$0.21 (Q3 2025), -$0.2 (Q2 2025), and -$0.22 (Q1 2025).